Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Parkinson disease | D010300 | EFO_0002508 | G20 | 2 | 9 | 1 | — | 4 | 14 |
Parkinsonian disorders | D020734 | — | G20.C | — | — | 1 | — | — | 1 |
Carbon monoxide poisoning | D002249 | — | — | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Alzheimer disease | D000544 | EFO_0000249 | F03 | 1 | 1 | — | — | 1 | 2 |
Healthy volunteers/patients | — | — | — | 1 | 1 | — | — | — | 2 |
Lewy body disease | D020961 | EFO_0006792 | G31.83 | 1 | 1 | — | — | — | 1 |
Dementia | D003704 | EFO_0003862 | F03 | 1 | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | 2 | — | — | — | 1 | 3 |
Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | 1 | — | — | — | 1 | 2 |
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 2 | — | — | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Brain neoplasms | D001932 | EFO_0003833 | C71 | — | — | — | — | 1 | 1 |
Epilepsy | D004827 | EFO_0000474 | G40.9 | — | — | — | — | 1 | 1 |
Progressive supranuclear palsy | D013494 | EFO_0002512 | G23.1 | — | — | — | — | 1 | 1 |
Anhedonia | D059445 | — | R45.84 | — | — | — | — | 1 | 1 |
Major depressive disorder | D003865 | EFO_0003761 | F22 | — | — | — | — | 1 | 1 |
Post-acute covid-19 syndrome | D000094024 | — | — | — | — | — | — | 1 | 1 |
Drug common name | — |
INN | — |
Description | — |
Classification | Unknown |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | — |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | — |